Lilly(Eli) & Co (NYSE:LLY) shares, rose in value, with the stock price up by 2.10% to the previous day’s close as strong demand from buyers drove the stock to $784.21.
Actively observing the price movement in the last trading, the stock closed the session at $768.08. The value of beta (5-year monthly) was 0.37 whereas the PE ratio was 137.95 over 12-month period. Referring to stock’s 52-week performance, its high was $800.78, and the low was $357.93. On the whole, LLY has fluctuated by 0.57% over the past month.
With the market capitalization of Lilly(Eli) & Co currently standing at about $745.60 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 30, 2024. The company’s Forward Dividend Ratio is 4.69, with its dividend yield at 0.60%. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $2.53, which is expected to increase to $3 for fiscal year $12.47 and then to about $18.25 by fiscal year 2025. Data indicates that the EPS growth is expected to be 97.30% in 2025, while the next year’s EPS growth is forecast to be 46.40%.
Analysts have estimated the company’s revenue for the quarter at $9.01 billion, with a low estimate of $8.6 billion and a high estimate of $9.7 billion. According to the average forecast, sales growth in current quarter could jump up 29.40%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $41.39 billion, representing an increase of 21.30% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that LLY’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.72, with the price of LLY currently trading nearly 2.34% and 5.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.10, while the 7-day volatility ratio is showing 2.65% which for the 30-day chart, stands at 2.42%. Furthermore, Lilly(Eli) & Co (LLY)’s beta value is 0.37, and its average true range (ATR) is 18.84.
A comparison of Lilly(Eli) & Co (LLY) with its peers suggests the former has fared considerably weaker in the market. LLY showed an intraday change of 2.10% in last session, and over the past year, it grew by 121.14%%.
Data on historical trading for Lilly(Eli) & Co (NYSE:LLY) indicates that the trading volumes over the past 10 days have averaged 2.53 million and over the past 3 months, they’ve averaged 3.12 million. According to company’s latest data on outstanding shares, there are 949.38 million shares outstanding.
Nearly 10.62% of Lilly(Eli) & Co’s shares belong to company insiders and institutional investors own 73.54% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.54 million shares as on Mar 15, 2024, resulting in a short ratio of 1.66. According to the data, the short interest in Lilly(Eli) & Co (LLY) stood at 0.58% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 5.15 million. The stock has risen by 34.53% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LLY stock heading into the next quarter.
